Skip to main content
. 2022 Aug 29;47(2):21. doi: 10.1186/s41110-022-00171-x

Table 3.

Comparison of WHOQOL-Bref domain mean scores with clinical data

Variable WHOQOL-Bref domain
Physical Psychological Social Environmental Overall QoL
Age (years)
  21–34 64.5 ± 16.7 72.86 ± 12.5 65.2 ± 27.8a 71.0 ± 11.0a 68.4 ± 13.2
  35–60 59.1 ± 16.4 67.4 ± 15.1 70.1 ± 19.5a 61.3 ± 12.1b 64.5 ± 11.9
  ≥ 60 58.6 ± 16.6 72.4 ± 12.0 81.1 ± 13.3b 67.0 ± 14.0a,b 69.8 ± 11.1
  p value 0.314* 0.169 0.010* 0.014 0.103
Gender
  Male 61.4 ± 16.4 71.7 ± 13.4 73.8 ± 17.8 65.4 ± 12.9 68.1 ± 11.4
  Female 55.6 ± 16.0 65.5 ± 14.3 71.5 ± 23.8 62.5 ± 13.2 63.8 ± 12.7
  p value 0.094 0.034 0.582 0.301 0.088
Etiology of CKD
  Hypertensive nephrosclerosis 59.3 ± 16.2 67.4 ± 13.3 69.7 ± 21.3 62.6 ± 14.1 64.8 ± 12.2
Diabetic nephropathy 55.3 ± 15.6 70.0 ± 16.6 78.0 ± 16.2 64.4 ± 13.8 66.9 ± 13.0
  Glomerulonephritis 64.3 ± 18.7 70.0 ± 19.7 68.0 ± 33.1 70.5 ± 11.1 68.2 ± 18.1
  Others 61.4 ± 16.7 72.2 ± 11.3 75.0 ± 15.3 65.0 ± 11.8 68.2 ± 9.3
  p value 0.459 0.523 0.601* 0.442 0.605
HD vintage
  3 months–1 year 71.1 ± 15.5 79.0 ± 9.1 77.5 ± 12.9 75.3 ± 9.4a 75.7 ± 9.0a
  1–5 years 58.0 ± 17.5 68.9 ± 14.1 72.0 ± 23.1 63.8 ± 14.3b 65.7 ± 13.0b
  ≥ 5 years 59.1 ± 14.4 68.8 ± 14.1 73.4 ± 16.0 62.7 ± 10.6b 66.0 ± 10.2a,b
  p value 0.065 0.089 0.809* 0.019 0.043
Mortality
  Yes 61.1 ± 9.2 67.7 ± 17.0 73.7 ± 20.2 62.5 ± 15.4 66.2 ± 11.3
  No 59.0 ± 15.3 69.9 ± 12.6 71.4 ± 20.3 64.6 ± 11.8 66.2 ± 14.2
  p value 0.582 0.486 0.645 0.519 0.995

QoL, quality of life, total score; CKD, chronic kidney disease; HD, hemodialysis. Values presented as mean ± standard deviation, with a significant difference for p ≤ 0.05, one-way ANOVA test or *Kruskal–Wallis test. Superscript letters (a, b) represent the statistical analysis: different letters mean significant differences